Gunakan kata kunci seperti ARV, PrEP, efek samping, tes HIV, dukungan sebaya, atau nama wilayah.
...n HIV selama rata-rata 11 tahun. Seperempat peserta positif untuk antibodi inti hepatitis B. Pada minggu ke-48, 1,5% dari mereka yang menerima doravarine/islatravir memiliki viral load di atas 50 kopi/ml dibandingkan den...
https://spiritia.or.id/artikel/detail/163... with HIV for a median of 11 years. A quarter of participants were positive for hepatitis B core antibody. At week 48, 1.5% of those on doravarine / islatravir had viral load above 50 copies/ml compared to 0.6% in the&nb...
https://spiritia.or.id/artikel/detail/163...h is used to treat people living with HIV. Meg Doherty, director of global HIV, hepatitis and sexually-transmitted infection (STI) programmes at the WHO, said efforts were being made to co-ordinate the sharing of vital s...
https://spiritia.or.id/artikel/detail/156...viral penyelamat jiwa bagi orang dengan HIV. Meg Doherty, Direktur Program HIV, Hepatitis, dan Infeksi Menular Seksual (IMS) Global WHO, mengatakan bahwa saat ini WHO berupaya mengoordinasikan pembagian stok obat penting...
https://spiritia.or.id/artikel/detail/156A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior vaccination, according to th...
https://spiritia.or.id/artikel/detail/152...verburdened health systems,” said Dr Meg Doherty, Director of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes at WHO. “Better prevention and treatment options are urgently needed to reduc...
https://spiritia.or.id/artikel/detail/146...yang sudah kewalahan,” kata Dr. Meg Doherty, Direktur Program HIV Global, Hepatitis, dan Infeksi Menular Seksual di WHO. “Pencegahan dan pengobatan yang lebih baik sangat diperlukan untuk mengurangi penularan...
https://spiritia.or.id/artikel/detail/146...sualnya. Tanggapan WHO Strategi sektor kesehatan global WHO tentang HIV, hepatitis virus, dan IMS 2022–2030 bertujuan untuk mengurangi 50% kasus baru trikomoniasis pada tahun 2030. WHO bekerja sama dengan ne...
https://spiritia.or.id/artikel/detail/137... partners. WHO Response WHO’s global health sector strategy on HIV, viral hepatitis and STIs 2022–2030 aims to reduce by 50% new cases of trichomoniasis by 2030. WHO is working with countries and partners to ...
https://spiritia.or.id/artikel/detail/137...nd treatment strategies. The Global health sector strategies on HIV, viral hepatitis and STIs 2022–2030 aims for a 50% reduction in new cases of chlamydia by 2030. WHO is working with countries and partne...
https://spiritia.or.id/artikel/detail/141